SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 130 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $55,266,000 | +67.8% | 2,014,787 | +275.7% | 3.22% | +160.5% |
| Q3 2016 | $32,933,000 | +120.4% | 536,282 | -31.6% | 1.23% | +58.2% |
| Q2 2016 | $14,941,000 | +51.3% | 783,497 | +54.9% | 0.78% | +57.9% |
| Q1 2016 | $9,876,000 | +353.2% | 505,937 | +606.6% | 0.49% | +525.3% |
| Q2 2015 | $2,179,000 | +648.8% | 71,600 | +226.3% | 0.08% | +558.3% |
| Q1 2015 | $291,000 | -80.8% | 21,943 | -79.1% | 0.01% | -75.0% |
| Q4 2014 | $1,519,000 | -32.5% | 105,000 | -1.6% | 0.05% | -44.2% |
| Q3 2014 | $2,251,000 | -40.4% | 106,663 | -15.9% | 0.09% | -46.9% |
| Q2 2014 | $3,777,000 | -55.4% | 126,772 | -64.0% | 0.16% | -65.8% |
| Q1 2014 | $8,461,000 | -18.2% | 352,100 | -30.6% | 0.47% | -28.1% |
| Q4 2013 | $10,342,000 | -58.1% | 507,700 | -2.7% | 0.66% | -58.9% |
| Q3 2013 | $24,656,000 | +42.4% | 522,041 | +14.8% | 1.60% | +38.7% |
| Q2 2013 | $17,309,000 | – | 454,899 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |